Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRAMP: Tumor Necrosis Factor- α Blockade and AR Inhibition in Men With CRPC

NCT05960578 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05960578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05960578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRAMP: Tumor Necrosis Factor- α Blockade and AR Inhibition in Men With CRPC
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 23, 2024
Completion date
April 14, 2027
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate carcinoma, prostate adenocarcinoma, stage iv prostate cancer ajcc v8